Eplerenone and bradycardia Patient Reports February 13, 2012

Eplerenone Side Effects Report #5577419-9
Eplerenone side effect was reported by a Physician from JAPAN on Dec 19, 2007. Female patient, 70 years of age, was diagnosed with hypertension and was treated with Eplerenone. After drug was administered, patient experienced the following side effects: bradycardia. Eplerenone dosage: DAILY DOSE:50MG. During the same period patient was treated with ARTIST, CALBLOCK, CARDENALIN, LASIX. Patient recovered.

Eplerenone Side Effects Report #5599376-1
Eplerenone side effect was reported by a Physician from JAPAN on Jan 10, 2008. Female patient, weighting 85.98 lb, was diagnosed with hypertension, arrhythmia  and was treated with Eplerenone. After drug was administered, patient experienced the following side effects: bradycardia. Eplerenone dosage: DAILY DOSE:50MG-FREQ:QD. During the same period patient was treated with ARTIST, CALBLOCK, LASIX, MEXITIL, CARDENALIN, IMIDAPRIL HYDROCHLORIDE, NORVASC, OLMESARTAN MEDOXOMIL. Patient was hospitalized. Patient recovered.

Eplerenone Side Effects Report #5614304-8
Eplerenone side effect was reported by a Physician from JAPAN on Jan 24, 2008. Female patient, weighting 85.98 lb, was diagnosed with hypertension, arrhythmia  and was treated with Eplerenone. After drug was administered, patient experienced the following side effects: bradycardia. Eplerenone dosage: unknown. During the same period patient was treated with ARTIST, CALBLOCK, LASIX, MEXITIL, CARDENALIN, IMIDAPRIL HYDROCHLORIDE, NORVASC, OLMETEC. Patient was hospitalized. Patient recovered.

Eplerenone Side Effects Report #5962588-9
Eplerenone side effect was reported by a Physician from JAPAN on Nov 12, 2008. Female patient, 88 years of age, was treated with Eplerenone. After drug was administered, patient experienced the following side effects: bradycardia, hyperkalaemia. Eplerenone dosage: DAILY DOSE:50MG. During the same period patient was treated with VALSARTAN, NORPACE. Patient was hospitalized. Patient recovered.